Trademark: 88977778
Word
PAPA & BARKLEY RELEAF
Status
Dead
Status Code
602
Status Date
Friday, October 14, 2022
Serial Number
88977778
Mark Type
3000
Filing Date
Monday, February 25, 2019
Abandoned Date
Friday, September 23, 2022

Trademark Owner History

Classifications
5 Mentholated ointment for medical use, all of the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; Medicated skin oils, all of the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; Topical analgesics, all of the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; Analgesic balm, all of the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; Medicated skin creams and lotions, all of the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; medicated skin care preparations, all of the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; medicated herbal topical creams, gels, skin sprays, balms, liniment and ointments, all the foregoing for the relief of pain, all of the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; Topical gel for medical and therapeutic treatment of minor aches and pains of muscles and joints, all of the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; Herbal tinctures for medical purposes, all of the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; Orally-ingestible herbal tinctures for medicinal purposes in the nature of nutritional and dietary supplements, all of the foregoing containing only naturally-occurring levels of CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; Medicated oral spray for pain, all of the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; Pharmaceutical, medicinal, medicated herbal, medicated botanical, and medicated preparations in the form of salves, concentrates, pastes, extracts, tinctures, and mucous membrane doses, for use in connection with pain, muscle tension, muscle spasms, and gastrointestinal illness, all of the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; Specialized tablets, capsules and powders for the delivery of pharmaceuticals sold without the pharmaceutical ingredient, all of the foregoing containing no cannabis and no cannabinoids, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; Muscle soaks, all of the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act
The mark consists of the stylized wording "PAPA & BARKLEY RELEAF" in blue. In between the words "PAPA" and "BARKLEY" is the ampersand sitting inside a blue outline of a circle with a narrow blue leaf running through the ampersand. The wording "RELEAF" sits below the wording "PAPA". The white in the drawing is for background areas only and is not a feature of the mark.
PAPA AND BARKLEY RELIEF
The color(s) blue is/are claimed as a feature of the mark.

Trademark Events
Oct 14, 2022
Abandonment Notice E-Mailed - Failure To Respond
Oct 14, 2022
Abandonment Notice Mailed - Failure To Respond
Oct 14, 2022
Abandonment - Failure To Respond Or Late Response
Mar 22, 2022
Notification Of Subsequent Final Emailed
Mar 22, 2022
Subsequent Final Emailed
Mar 22, 2022
Subsequent Final Refusal Written
Sep 29, 2021
Divisional Processing Complete
Sep 24, 2021
Divisional Request Received
Sep 24, 2021
Teas Request To Divide Received
Jun 5, 2021
Teas/Email Correspondence Entered
Jun 4, 2021
Correspondence Received In Law Office
Jun 4, 2021
Teas Response To Office Action Received
Mar 10, 2021
Teas Change Of Correspondence Received
Mar 10, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 10, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 7, 2020
Notification Of Non-Final Action E-Mailed
Dec 7, 2020
Non-Final Action E-Mailed
Dec 7, 2020
Non-Final Action Written
Jun 15, 2020
Notification Of Final Refusal Emailed
Jun 15, 2020
Final Refusal E-Mailed
Jun 15, 2020
Final Refusal Written
May 13, 2020
Notice Of Design Search Code E-Mailed
May 12, 2020
Divisional Processing Complete
Apr 29, 2020
Divisional Request Received
May 11, 2020
Case Assigned To Intent To Use Paralegal
May 11, 2020
Teas/Email Correspondence Entered
Apr 29, 2020
Correspondence Received In Law Office
May 4, 2020
Assigned To Lie
Apr 29, 2020
Teas Response To Office Action Received
Apr 29, 2020
Teas Request To Divide Received
Oct 29, 2019
Notification Of Non-Final Action E-Mailed
Oct 29, 2019
Non-Final Action E-Mailed
Oct 29, 2019
Non-Final Action Written
Oct 28, 2019
Assigned To Examiner
May 6, 2019
Assigned To Examiner
May 6, 2019
Assigned To Examiner
Mar 21, 2019
Notice Of Design Search Code E-Mailed
Mar 15, 2019
New Application Office Supplied Data Entered
Feb 28, 2019
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24